LEXARIA BIOSCIENCE CORP. Other Comprehensive Income (Loss), Net of Tax
LEXARIA BIOSCIENCE CORP. (LEXX) reported Other Comprehensive Income (Loss), Net of Tax of -$1.77 million for the 3-month period ending 2022-11-30, per its 10-Q/A filed 2023-01-18.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2023-01-18
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), net of tax for the quarter ending 2022-11-30 was -$1.77M.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), net of tax for the quarter ending 2021-11-30 was -$2.00M.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), net of tax for the quarter ending 2018-11-30 was $14.25K.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), net of tax for the quarter ending 2018-08-31 was -$6.86K.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), net of tax for fiscal 2022 was -$7.38M.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), net of tax for fiscal 2021 was -$4.19M.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), net of tax for fiscal 2019 was $14.25K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2022-11-30 | -$1.77M 10-Q/A · filed 2023-01-18 | |||
| 2022-08-31 | -$7.38M 10-K · filed 2022-11-28 | |||
| 2021-11-30 | -$2.00M 10-Q/A · filed 2023-01-18 | |||
| 2021-08-31 | -$4.19M 10-K · filed 2022-11-28 | |||
| 2019-08-31 | $14.25K 10-K · filed 2020-10-15 | |||
| 2018-11-30 | $14.25K 10-Q · filed 2019-01-11 | $7.38K derived: sum of 2 quarters · filed 2019-07-08 | $0.00 derived: sum of 3 quarters · filed 2019-07-08 | |
| 2018-08-31 | -$6.86K 10-Q · filed 2019-07-08 | -$14.25K derived: sum of 2 quarters · filed 2019-07-08 | -$14.25K 10-Q · filed 2020-01-09 | |
| 2018-05-31 | -$7.38K 10-Q · filed 2019-07-08 | -$7.38K 10-Q · filed 2018-07-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |